logo
Sign in

ATRS Stock Price, Chart, Stats & News

Antares Pharma, Inc.
Save
Market cap
14.95x
Current P/E
Forward P/E

ATRS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
62.89%
Operating margin
33.85%
Pretax margin
33.85%
Net margin
25.16%
Effective tax rate
25.67%
ROA
17.98%
ROE
31.40%
D/E
0.14x
Interest coverage ratio

ATRS valuation

P/E
14.95x
P/S
P/B
5.41x
P/CF
25.97x
P/FCF
P/OCF
25.97x
PEG
0.21x
EV multiple
0.63x

About

Antares Pharma, Inc. operates as a specialized pharmaceutical enterprise, primarily dedicated to innovating and marketing medicines and advanced technologies. Its core mission is to address critical patient needs across a range of therapeutic areas. The company achieves this by developing, manufacturing, and commercializing groundbreaking therapeutic products, often leveraging its distinctive drug delivery systems.

Similar securities

Based on sector and market capitalization

Report issue